Wed, July 12, 2023
Tue, July 11, 2023
Mon, July 10, 2023
Sun, July 9, 2023
Fri, July 7, 2023

Gregory Renza Reiterated (VRDN) at Buy and Held Target at $44 on, Jul 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-44-on-jul-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $44 on, Jul 11th, 2023.

Gregory has made no other calls on VRDN in the last 4 months.



There are 4 other peers that have a rating on VRDN. Out of the 4 peers that are also analyzing VRDN, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Gregory


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $40 on, Wednesday, May 10th, 2023
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023

Publication Contributing Sources